Black Rock Inc. Rhythm Pharmaceuticals, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RYTM
# of Institutions
177Shares Held
68.5MCall Options Held
467KPut Options Held
224K-
Primecap Management CO Pasadena, CA7.31MShares$359 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$314 Million3.49% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$298 Million3.77% of portfolio
-
Goldman Sachs Group Inc New York, NY5.29MShares$259 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.45MShares$169 Million4.09% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.73B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...